US drugmakers rise after Trump announces Pfizer price cuts, promises more deals
PositiveFinancial Markets

US drugmakers saw a surge in stock prices following President Trump's announcement of price cuts for Pfizer medications. This move is significant as it reflects the administration's commitment to lowering drug costs for consumers, potentially leading to more affordable healthcare options. Investors are optimistic about the future of the pharmaceutical industry, anticipating further deals that could enhance market stability and accessibility.
— Curated by the World Pulse Now AI Editorial System